Pfizer (PFE) Tops Q2 EPS by 7c, Updates Guidance

Pfizer (NYSE: PFE) reported Q2 EPS of $0.81, $0.07 better than the analyst estimate of $0.74. Revenue for the quarter came in at $13.47 billion versus the consensus estimate of $13.31 billion.

GUIDANCE:

Pfizer sees FY2018 EPS of $2.95-$3.05, versus the consensus of $2.95. Pfizer sees FY2018 revenue of $53-55 billion, versus the consensus of $54.3 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Redburn upgrades Southwest, stays bullish on Delta and United
• Deutsche Bank Reiterates Buy Rating on Volkswagen AG (VOW:GR) (VWAGY)